home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Maximum Fair Price Strategies for IPAY2027 Readiness

 
  October 17, 2025  
     
 
Xtalks, Online
2025-11-10


As Medicare’s drug negotiation program enters its second year, stakeholders face growing uncertainty about how maximum fair price (MFP) determinations will reshape drug access, market competition and regulatory expectations. The shift from Year 1 to Year 2 introduces new challenges around pricing methodology, stakeholder alignment and downstream financial implications across the healthcare ecosystem. Join this webinar to explore the impact of Year 2 MFP decisions, including comparisons with Year 1, stakeholder impact and broader effects on competitiveness, coverage and patient access.

The featured speakers will examine how the Centers for Medicare & Medicaid Services’ (CMS) approach has evolved, including shifts in price-setting logic and lessons learned from IPAY2026. They will assess how different stakeholders may be affected by these changes, particularly in terms of who stands to gain or face new constraints under fixed pricing. The webinar will also consider how the Trump administration might influence Medicare pricing policy and whether more aggressive approaches to MFP determinations could emerge. Using real-world observations, the panel will highlight how current MFP decisions are influencing contracting strategies and shaping competitive responses across therapeutic areas.

Register for this webinar to learn how the MFP process is evolving and what it means for manufacturers, payers and policymakers navigating the Medicare landscape.

Keywords: Centers for Medicare and Medicaid Services, Commercialization/HEOR/Market Access, Drug Prices, Health Insurance, Healthcare Policy, Marketing, Medicare, Medicare Drug Price Negotiations, Payers, Regulatory
 
 
Organized by: Xtalks
Invited Speakers: Mike Ciarametaro, Policy Managing Director, Avalere Health (Moderator)
Neil Lund, Senior Advisor, Avalere Health
Milena Sullivan, SVP, Healthcare Policy Practice Director, Avalere Health
Taylor Schwartz, Evidence & Strategy Managing Director, Avalere Health
 
Deadline for Abstracts: 2025-11-10
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2025 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.